Oxeia Biopharma in the News

“I became an advisor to Oxeia to contribute to an action that could change the face of how concussions are treated.   Wouldn’t it be great if football players, hockey players and boxers, among others, could play their sport without the constant worry of repercussions from getting walloped in the head? Oxeia’s progress toward the delivery of a treatment for concussions fills me with great excitement about the future of sports.”

Richard Sherman
Cornerback for the San Francisco 49ers
and
Advisory Board Member, Oxeia Biopharmaceuticals